Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06605469
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-06-13
Brief Title:
Ejaculatory and Orgasmic Dysfunction Registry
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Ejaculatory and Orgasmic Dysfunction Registry Climax Registry
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to evaluate the safety and efficacy of various therapies used to treat ejaculatory andor orgasmic dysfunctions in men The objective is to create a large national registry designed to capture key outcomes for men being treated for ejaculatory andor orgasmic dysfunction
Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals
Participants will submit questionnaires about their diagnosis and treatment efficacy and multiple time intervals
Detailed Description:
The objective of the current study is to create a large national registry designed to capture key outcomes for men being treated for ejaculatory andor orgasmic dysfunction To accomplish this registry CURE PD has partnered with the Sexual Medicine Society of North America SMSNA to help inform sexual medicine providers of the existence of the study and to help encourage patients to enroll
Subjects meeting criteria will be offered study entry by their local provider who will refer them to an email address to indicate their interest Participants will then be administered questionnaires at baseline and every 3 months x 1 year followed by every 6 months x 2 years Patient partners will also be allowed to enroll and will receive questionnaires on the same schedule baseline q3 months x 1 year q6 months x 2 years
Subjects meeting criteria will be offered study entry by their local provider who will refer them to an email address to indicate their interest Participants will then be administered questionnaires at baseline and every 3 months x 1 year followed by every 6 months x 2 years Patient partners will also be allowed to enroll and will receive questionnaires on the same schedule baseline q3 months x 1 year q6 months x 2 years
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None